How 24-hour sleep loss affects people with different APOE genes
Official title: Effects of Acute Sleep Deprivation on Individuals With Different APOE Genotypes
Run by Guangdong Provincial Hospital of Traditional Chinese Medicine · NCT07085754 · Data updated 2026-11-12
This will see if 24 hours without sleep changes blood Alzheimer's-related markers in healthy adults with different APOE gene types.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 40 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Guangdong Provincial Hospital of Traditional Chinese Medicine Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | August 8, 2025 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2026 |
| Registry record updated | December 24, 2025 |
| Trial ID | NCT07085754 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Healthy adults 18–40 years old who normally sleep 7–9 hours per night, are cognitively normal, not taking regular medications, and willing to undergo a 24-hour overnight visit and blood draws are ideal candidates.
✕Probably not a fit
People with cognitive impairment, older adults, recent shift workers or travelers, current smokers, heavy drinkers, or those on regular medications are unlikely to be eligible or to benefit from this specific protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial will enroll 60 healthy adults aged 18–40 and stratify them by APOE genotype (ε3/3, ε4 carriers, and ε2 carriers). Within each genotype stratum participants will be randomly assigned to either 24 hours of acute sleep deprivation or to normal sleep. Blood samples will be collected before and after the intervention to measure plasma Aβ42 and a range of multi-omics biomarkers, with the primary outcome being the change in plasma Aβ42 the day after randomization. The design tests whether a single night of sleep loss produces different molecular responses depending on APOE genotype.
Why it matters
Potential benefit: If successful, the results could help identify how brief sleep loss affects Alzheimer's-related blood markers by genetic risk and inform targeted prevention or monitoring strategies.
How similar studies have gone: Prior short-term sleep deprivation studies have reported changes in CSF and blood Aβ and tau, but combining stratified APOE genotyping with multi-omics profiling is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18-40 years, gender not limited * Healthy (with no clinically significant abnormal findings in the physical examination report or self-reporting as healthy) and not on medications * Cognitively normal (Mini-Mental State Examination (MMSE) score \> 28) * Sleep duration of 7-9 hours per night, good sleep quality (Pittsburgh Sleep Quality Index (PSQI) ≤ 5 points) * Written informed consent, voluntarily participate in this study, and be able to cooperate with the physician to complete the clinical study Exclusion Criteria: * Presence of day-night sleep reversal * Shift work within the past 6 months * Travel across time zones or experience of jet lag within the past three weeks * Current smoking or nicotine use; alcohol consumption exceeding five standard units per week (one standard alcohol unit is defined as 10 mL \[or 8 g\] of pure alcohol) * Consumption of strong tea, coffee, or caffeine-containing foods and beverages within one week before study participation * Family history of early-onset dementia * Self-Rating Depression Scale (SDS) score ≥ 53, Self-Rating Anxiety Scale (SAS) score ≥ 50 * Female participants who are currently pregnant or breastfeeding * Individuals who need to drive or operate vehicles or machinery during the study period
Where it's running
-
Guangdong Provincial Hospital of Chinese Medicine
Guangzhou, Guangdong, China Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sleep and circadian care for ICU patients
This study tests a multicomponent sleep and circadian rhythm program in adult ICU patients to see if it helps keep daily rhythms and sleep better.
-
HBS-104 single doses in acutely sleep-deprived healthy adults
This study tests whether a single dose of HBS-104 is safe and how it behaves in the body when given to healthy adults who are acutely sleep-deprived.
-
Mind After Midnight — how being awake between 2:00 and 4:00 AM affects mood and decision-making
This project will test whether being awake during the biological night (2:00–4:00 AM) increases negative mood, poor decision-making, and suicidal thoughts in adults who have had suicidal ideation in the past six months.
-
Nighttime synchronization of eating and your circadian clock
This trial will test whether changing light exposure and when you eat during short sleep periods changes metabolism in healthy adults aged 18–35 who normally sleep 7–9 hours per night.
-
How the body clock affects time perception during 36 hours awake
This test will see if the internal body clock and staying awake for about 36 hours change how healthy adults experience and estimate time.
-
Effects of Sleep Loss and Alcohol on Brain and Performance in Healthy Adults
This study tests how sleep deprivation and moderate alcohol use affect thinking and motor skills in healthy adults to understand risks that could relate to spaceflight.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.